FDMT CLO sells 6,566 shares, exercises options
4D Molecular Therapeutics Chief Legal Officer Scott Bizily reported an option exercise-and-sale transaction in company stock.
Rhea-AI Filing Summary
4D Molecular Therapeutics Chief Legal Officer Scott Bizily reported an option exercise-and-sale transaction in company stock. On June 30, 2026, he sold 6,566 shares of common stock at $14.00 per share in an open-market transaction made pursuant to a Rule 10b5-1 trading plan adopted on January 13, 2026.
On the same date, he exercised stock options covering 5,752 shares at an exercise price of $6.49 per share and 814 shares at $4.14 per share, converting these derivative awards into common shares. The options exercised were from grants originally scheduled to vest monthly over four years and carried expiration dates in 2032 and 2035.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 6,566 shares ($51K approx. pre-tax spread)
Exercise and Sale
5 txns
Insider
Bizily Scott
Role
Chief Legal Officer
Sold
6,566 shs ($92K)
Approx. gross sale proceeds
$92K
Approx. exercise cost
$41K
Approx. pre-tax spread
$51K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 814 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 5,752 | $0.00 | $0.00 |
| Exercise | Common Stock | 814 | $4.14 | $3K |
| Exercise | Common Stock | 5,752 | $6.49 | $37K |
| Sale | Common Stock | 6,566 | $14.00 | $92K |
Holdings After Transaction:
Stock Option (Right to Buy) — 66,514 contracts (Direct);
Common Stock — 8,617 shares (Direct)
Footnotes (3)
- F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on January 13, 2026.
- F2. The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.
- F3. The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of June 16, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.
Key Figures
Shares sold: 6,566 shares
Sale price: $14.00 per share
Options exercised (grant 1): 5,752 shares at $6.49
+4 more
7 metrics
Shares sold
6,566 shares
Common stock sold on June 30, 2026
Sale price
$14.00 per share
Open-market sale of 6,566 common shares
Options exercised (grant 1)
5,752 shares at $6.49
Stock options exercised into common stock
Options exercised (grant 2)
814 shares at $4.14
Stock options exercised into common stock
10b5-1 plan adoption
January 13, 2026
Plan governing June 30, 2026 open-market sale
Option expiration (grant 1)
June 17, 2032
Expiration date for $6.49 strike options
Option expiration (grant 2)
March 5, 2035
Expiration date for $4.14 strike options
Key Terms
Rule 10b5-1 trading plan, Stock Option (Right to Buy), derivative security, Vesting Commencement Date, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on January 13, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" with underlying security title Common Stock."
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security" for the option exercises."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Vesting Commencement Date financial
"on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
open-market sale financial
"transaction_action: "open-market sale" for 6,566 common shares at $14.00 per share."
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did FDMT Chief Legal Officer Scott Bizily report?
Scott Bizily reported selling 6,566 FDMT common shares and exercising stock options for an equal 6,566 shares. The sale occurred at $14.00 per share, while the options were exercised at $6.49 and $4.14 per share.
Was Scott Bizily’s FDMT stock sale under a Rule 10b5-1 plan?
Yes, the open-market sale of 6,566 FDMT shares was executed under a pre-arranged Rule 10b5-1 trading plan adopted on January 13, 2026. Such plans automate trades, reducing the significance of trade timing decisions.
What type of options did Scott Bizily exercise in this FDMT Form 4?
He exercised stock options (Right to Buy) for 5,752 underlying FDMT shares at a $6.49 exercise price and 814 shares at a $4.14 exercise price, converting these derivative awards into common stock on June 30, 2026.
When do the FDMT stock options exercised by Scott Bizily expire?
The exercised options originated from grants with expiration dates in 2032 and 2035. Specifically, one grant expires on June 17, 2032, and another on March 5, 2035, reflecting long-dated equity awards tied to prior service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
